☆ 4.5 Letter

The association of hypertension and diabetes pharmacotherapy with COVID-19 severity and immune signatures: an observational study

EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2021)

Get Full Text
Add to Collection

Journal

EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY
Volume 7, Issue 3, Pages E48-E51

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/ehjcvp/pvaa098

Keywords

Hypertension; Diabetes; Angiotensin-converting enzyme inhibitor (ACE-I); Angiotensin receptor blocker (ARB); Dipeptidyl peptidase 4 inhibitor (DPP4i)

Categories

Cardiac & Cardiovascular Systems Pharmacology & Pharmacy

Funding

  1. NMRC COVID-19 research fund [COVID19RF-001]
  2. A*STAR COVID-19 Research fund [H/20/04/g1/006]
  3. National Research Foundation [NRF2017_SISFP09]
  4. Ministry of Health, Clinician Scientist Award [MOH-000014]
  5. National Medical Research Council Centre Grant [NMRC/CG/017/2013]

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.